JPRN-jRCT1080224753招募中Unknown
Specified Drug-Use Survey on Entyvio for IV Infusion 300 mg [Crohn's Disease]
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •1. Have moderate or severe active CD
- •2. Have inadequate response to existing therapies
排除标准
- •1. Patients with any contraindication for vedolizumab
研究者
相似试验
已完成
Unknown
Specified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Ulcerative Colitis]JPRN-jRCT1080224534Takeda Pharmaceutical Company Limited1,096
招募中
不适用
uwiq for i.v. injection Drug use-result surveyHemophilia AJPRN-UMIN000047344Fujimoto Pharmaceutical Corp.20
已完成
不适用
Therapeutic Drug Monitoring of Intravenous Busulfan in Thai Children Undergoing Hematopoietic Stem Cell Transplantation: A Pilot StudyAllogeneic hematopoietic stem cell transplantation (HSCT) is widely used as a primary treatment for various malignant disorders (eg,acute myeloid leukemia) and non-malignant disorders (eg,thalassemibusulfantherapeutic drug monitoringarea under the curvetransplantationchildrenTCTR20190528003Faculty of Medicine, Mahidol University, Thailand10
招募中
不适用
Clinical study of the use of Bevacizumab in glaucoma surgery.RBR-9wkw73jnião Metropolitana de Educação e Cultura
已完成
不适用
Clinical trial to determine safety and efficacy of intravenous silver nanoparticles in severe covid patientsCTRI/2021/09/036781Dr Subhasish Sarkar40